MX366496B - Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use. - Google Patents

Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use.

Info

Publication number
MX366496B
MX366496B MX2014010152A MX2014010152A MX366496B MX 366496 B MX366496 B MX 366496B MX 2014010152 A MX2014010152 A MX 2014010152A MX 2014010152 A MX2014010152 A MX 2014010152A MX 366496 B MX366496 B MX 366496B
Authority
MX
Mexico
Prior art keywords
methods
eslicarbazepine acetate
pharmaceutical compositions
present disclosure
preparing pharmaceutical
Prior art date
Application number
MX2014010152A
Other languages
Spanish (es)
Inventor
Luis De Almeida Jose
Manuel Vieira Araújo Soares Da Silva Patrício
Original Assignee
Bial Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela & Ca Sa filed Critical Bial Portela & Ca Sa
Publication of MX366496B publication Critical patent/MX366496B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
MX2014010152A 2005-05-06 2005-05-06 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use. MX366496B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2005/002357 WO2006120501A1 (en) 2005-05-06 2005-05-06 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use

Publications (1)

Publication Number Publication Date
MX366496B true MX366496B (en) 2019-07-11

Family

ID=35335795

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014010152A MX366496B (en) 2005-05-06 2005-05-06 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use.
MX2007013882A MX2007013882A (en) 2005-05-06 2005-05-06 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2007013882A MX2007013882A (en) 2005-05-06 2005-05-06 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use.

Country Status (5)

Country Link
AU (1) AU2005331690C1 (en)
BR (1) BRPI0520258A2 (en)
CA (1) CA2607427C (en)
MX (2) MX366496B (en)
WO (1) WO2006120501A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121363A1 (en) * 2005-05-06 2006-11-16 Portela & C.A., S.A. Eslicarbazepine acetate and methods of use
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
GB0700773D0 (en) * 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
WO2008095221A1 (en) 2007-02-07 2008-08-14 Gosforth Centre (Holdings) Pty Ltd Treatment of adhd
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
US20110207718A1 (en) * 2008-08-06 2011-08-25 Gosforth Centre (Holdings) Pty Ltd. Compositions and methods for treating psychiatric disorders
WO2011014084A1 (en) 2009-07-27 2011-02-03 Bial - Portela & Ca., S.A. Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia
UA115420C2 (en) * 2010-12-31 2017-11-10 Біал-Портела Енд Ка., С.А. Grznulates comprising eslicarbazepine acetate
RU2639120C2 (en) 2011-08-26 2017-12-19 Биал-Портела Энд Ка, С.А. Treatment using eslicarbazepine acetate or eslicarbazepine
GB201306095D0 (en) * 2013-04-04 2013-05-22 Bial Portela & Ca Sa New treatments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101732B (en) * 1995-06-30 1997-12-31 Portela & Ca Sa SUBSTITUTED AZEPINES PROCESS FOR THE PREPARATION OF THE PHARMACEUTICAL COMPOSITIONS CONTAINED THEREOF AND USES OF THE NEW COMPOUNDS IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS EMPLOYED IN DISEASES OF THE NERVOUS SYSTEM
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders

Also Published As

Publication number Publication date
AU2005331690B2 (en) 2012-09-20
WO2006120501A1 (en) 2006-11-16
AU2005331690C1 (en) 2013-01-17
MX2007013882A (en) 2008-01-28
CA2607427C (en) 2015-11-24
AU2005331690A1 (en) 2006-11-16
BRPI0520258A2 (en) 2009-09-15
CA2607427A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
MX366496B (en) Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use.
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
MX2010004494A (en) Use of trkb antibodies for the treatment of respiratory disorders.
TW200606162A (en) Pyrazolopyridine derivatives
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
MX2012003555A (en) Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same.
ZA200810194B (en) "use of arylcarboxylic acid biphenylmides for seed treatment"
MX2009006327A (en) Heterocycle compounds and methods of use thereof.
EP2099449A4 (en) Pharmaceutical composition for the treatment and prevention of diseases involving impotence
SI2176252T1 (en) 2, 3-dihydrobenzoš1, 4ćdioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
EP2217238A4 (en) Methods and compositions for the treatment of proteinuric diseases
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
IL216967B (en) 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives and use thereof for the treatment of diseases
MX2010009624A (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1.
AR055939A1 (en) METHODS TO PREPARE PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACETATO DE ESLICARBAZEPINA AND METHODS OF USE
SG141358A1 (en) Treatment of psychiatric patients with reduced heptaic function with paliperidone
TNSN08506A1 (en) Substituted carboxamides
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
MX2012007234A (en) Calcipotriol monohydrate nanocrystals.
WO2010085799A9 (en) Compositions and method for the treatment of parkinson's disease
EP2716285A3 (en) New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
SG10201809506TA (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
WO2010028130A3 (en) Antidepressant compounds